Forward Citations = 19

Loading Chart...

4 inventors (with patents filed for the assignee):

Ronald D Schoenwald (2 out of 28 patents)

Bruno Silvestrini (1 out of 30 patents)

Bosko Jovicevic (1 out of 1 patent)

4. C Yan Cheng (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 6001865 - 3-substituted 1-benzyl-1H-indazole derivatives as antifertility agents (1999-12-14),

2. 5129720 - Method and apparatus for examination of visual acuity (1992-07-14),

3. 4879304 - Ophthalmic compositions and process for preparing (1989-11-07),

4. 4879294 - Opthalmic composition (1989-11-07),

Company Overview

Angelini Pharmaceuticals is a global healthcare company specializing in the research, development, and marketing of pharmaceutical and healthcare products. With a focus on mental health and pain management, Angelini Pharmaceuticals strives to improve the quality of life for patients around the world. With a presence in over 60 countries, Angelini Pharmaceuticals is committed to innovation, sustainability, and ethical business practices.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#2 in River Edge, NJ

#2,203 in New Jersey

#60,641 in US

River Edge, NJ, United States of America

Angelini Pharmaceuticals

Forward Citations = 19

4 inventors:

Ronald D Schoenwald (2 out of 28 patents)

Bruno Silvestrini (1 out of 30 patents)

Bosko Jovicevic (1 out of 1 patent)

4. C Yan Cheng (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Angelini Pharmaceuticals. Retrieved from https://idiyas.com/company/angelini-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]